Provided by Tiger Fintech (Singapore) Pte. Ltd.

EFH Ltd

0.023
+0.0014.55%
Volume:52.40K
Turnover:1.20K
Market Cap:39.87M
PE:-12.53
High:0.023
Open:0.023
Low:0.022
Close:0.022
52wk High:0.033
52wk Low:0.008
Shares:1.73B
Float Shares:559.06M
Volume Ratio:0.06
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.002
EPS(LYR):-0.003
ROE:-1275.15%
ROA:-62.22%
PB:35.85
PE(LYR):-6.57

Loading ...

Company Profile

Company Name:
EFH Ltd
Exchange:
SGX
Establishment Date:
2009
Employees:
7
Office Location:
18 Howard Road,No.11-09 Novelty BizCentre,Singapore,Singapore
Zip Code:
369585
Fax:
- -
Introduction:
Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singapore’s Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.